LCK
Top inhibitors
| Drug | Inhibition % | Gini |
|---|---|---|
| Dasatinib | 100.0 | 0.70 |
| Nintedanib | 100.0 | 0.61 |
| Ponatinib | 99.7 | 0.53 |
| Bosutinib | 99.7 | 0.55 |
| Neratinib | 99.3 | 0.60 |
| Vandetanib | 98.9 | 0.72 |
| Repotrectinib | 98.6 | 0.61 |
| Pacritinib | 98.4 | 0.45 |
| Vemurafenib | 98.4 | 0.60 |
| Ibrutinib | 98.0 | 0.72 |
| Canertinib | 97.7 | 0.67 |
| Tivozanib | 97.5 | 0.67 |
| Cabozantinib | 97.5 | 0.75 |
| Ripretinib | 97.2 | 0.67 |
| Crizotinib | 96.8 | 0.58 |
Known variants
No variants catalogued.